Trial intelligence / Profile preview

Carvedilol for prevention of heart failure in breast cancer patients receiving trastuzumab or anthracyclines

IRCT2017042433619N1Phase 3Completed

Sponsor
Baqiyatallah University of Medical Sciences
Start
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of carvedilol in breast cancer, sponsored by Baqiyatallah University of Medical Sciences. Started Jun 2017; status: completed.

02

Drugs

carvedilol
03

Conditions

breast cancer

Beyond the preview

Go deeper on IRCT2017042433619N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017042433619N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call